258 related articles for article (PubMed ID: 29232270)
1. Novel focal therapy treatment options for prostate cancer.
Werntz RP; Eggener SE
Curr Opin Urol; 2018 Mar; 28(2):178-183. PubMed ID: 29232270
[TBL] [Abstract][Full Text] [Related]
2. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
[TBL] [Abstract][Full Text] [Related]
3. MR-guided biopsy and focal therapy: new options for prostate cancer management.
Elkhoury FF; Simopoulos DN; Marks LS
Curr Opin Urol; 2018 Mar; 28(2):93-101. PubMed ID: 29232269
[TBL] [Abstract][Full Text] [Related]
4. Focal therapy of prostate cancer.
Hübner N; Shariat SF; Remzi M
Curr Opin Urol; 2018 Nov; 28(6):550-554. PubMed ID: 30239415
[TBL] [Abstract][Full Text] [Related]
5. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
Eggener SE; Yousuf A; Watson S; Wang S; Oto A
J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
[TBL] [Abstract][Full Text] [Related]
6. Target ablation--image-guided therapy in prostate cancer.
Marien A; Gill I; Ukimura O; Betrouni N; Villers A
Urol Oncol; 2014 Aug; 32(6):912-23. PubMed ID: 24411788
[TBL] [Abstract][Full Text] [Related]
7. Partial gland ablation in the management of prostate cancer: a review.
McClure TD; Margolis DJ; Hu JC
Curr Opin Urol; 2017 Mar; 27(2):156-160. PubMed ID: 28033149
[TBL] [Abstract][Full Text] [Related]
8. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
[TBL] [Abstract][Full Text] [Related]
9. Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials).
Noweski A; Roosen A; Lebdai S; Barret E; Emberton M; Benzaghou F; Apfelbeck M; Gaillac B; Gratzke C; Stief C; Azzouzi AR
Eur Urol Focus; 2019 Nov; 5(6):1022-1028. PubMed ID: 29661587
[TBL] [Abstract][Full Text] [Related]
10. New advances in focal therapy for early stage prostate cancer.
Tay KJ; Schulman AA; Sze C; Tsivian E; Polascik TJ
Expert Rev Anticancer Ther; 2017 Aug; 17(8):737-743. PubMed ID: 28635336
[TBL] [Abstract][Full Text] [Related]
11. Current status and progress of focal therapy in Asia.
Shiraishi T; Ukimura O
Curr Opin Urol; 2018 Nov; 28(6):529-535. PubMed ID: 30102622
[TBL] [Abstract][Full Text] [Related]
12. Radical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results.
Pierrard V; Lebdai S; Kleinclauss F; Azzouzi AR; Terrier JE; Fortier E; Joniau S; Van Der Poel H; Salomon G; Casanova J; Medina-Lopez RA; Potiron E; Rigaud J; Vincendeau S; Rassweiler J; Villers A; Gaston R; Saussine C; Giai J; Gaillac B; Emberton M; Ruffion A
J Urol; 2019 Feb; 201(2):315-321. PubMed ID: 30248343
[TBL] [Abstract][Full Text] [Related]
13. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
Valerio M; Cerantola Y; Eggener SE; Lepor H; Polascik TJ; Villers A; Emberton M
Eur Urol; 2017 Jan; 71(1):17-34. PubMed ID: 27595377
[TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
15. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional localization and targeting of prostate cancer foci with imaging and histopathologic correlation: establishing a multidisciplinary team for quality improvement.
Aminsharifi A; Gupta RT; Huang J; Polascik TJ
Curr Opin Urol; 2018 Nov; 28(6):506-511. PubMed ID: 30239416
[TBL] [Abstract][Full Text] [Related]
17. MR-Guided High-Intensity Directional Ultrasound Ablation of Prostate Cancer.
Galgano SJ; Planz VB; Arora S; Rais-Bahrami S
Curr Urol Rep; 2021 Jan; 22(1):3. PubMed ID: 33403460
[TBL] [Abstract][Full Text] [Related]
18. Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer.
Lepor H; Llukani E; Sperling D; Fütterer JJ
Eur Urol; 2015 Dec; 68(6):924-6. PubMed ID: 25979568
[TBL] [Abstract][Full Text] [Related]
19. Primary Focal Therapy for Localized Prostate Cancer: A Review of the Literature.
Hayes M; Lin-Brande M; Isharwal S
Oncology (Williston Park); 2021 May; 35(5):261-268. PubMed ID: 33983695
[TBL] [Abstract][Full Text] [Related]
20. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.
Scheltema MJ; Postema AW; de Bruin DM; Buijs M; Engelbrecht MR; Laguna MP; Wijkstra H; de Reijke TM; de la Rosette JJMCH
Diagn Interv Radiol; 2017; 23(5):365-370. PubMed ID: 28830850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
